Neuromodulation Market - Global Industry Analysis

Neuromodulation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Pharmaceutical Report Format : PDF Report Code: ZMR-6514 Status : Upcoming

Description

Global Neuromodulation Market: Overview

Neuromodulation is the technology that alters or modulates the activity of the nerve by delivering pharmaceutical or electrical agents directly to a target area. Neuromodulation treatments and devices are life changing as they affect every area of the body and treat almost every symptom or disease right from tremors to headaches or urinary incontinence to spinal cord damage. For the next decade, neuromodulation is considered a major growing industry owing to its broad therapeutic scope and ongoing improvements in biotechnology.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Neuromodulation Market: Growth Factors

The global neuromodulation market is growing at a speedy rate. An increase in prevalence of neurological disorders, a wide range of neuromodulation applications, and growing awareness of neurodegenerative disorders are some of the crucial factors that are fostering the growth of the global market. The most common indication of neuromodulation is most frequently in the context of chronic pain relief. However, there are numerous applications of neuromodulation such as spinal cord stimulation for ischemic disorders, sacral nerve stimulation for pelvic disorders & incontinence, and deep brain stimulation (DBS) treatment for Parkinson's disease. In addition to this, in case of a cochlear implant restoring hearing, response is stimulated by neuromodulation devices in a deaf patient. All such factors in combination with the development of technology and increase in adoption of neuromodulation therapies are escalating the growth of the global neuromodulation market. Moreover, growing demand for non-invasive procedures for the treatment of diseases and growing geriatric population are also the factors that are propelling the growth of the global market. In addition to this, the enhancement of regulatory processes for developers by the regulatory bodies will further spur the growth of the market. Furthermore, innovations in the devices and treatment may offer several opportunities for the growth of the global neuromodulation market over the forecast period. However, the dearth of skilled professionals may impede the growth of the global neuromodulation market.

Surgical interventions are required by neuromodulation, but during the Covid-19 pandemic, the government shifted the healthcare care workers towards the treatment of covid-19 patients and postponed elective procedures and surgeries. The institutes are been hampered financially due to postponing of the procedures. The sales of neuromodulation devices also declined during the pandemic period. All such factors resulted in the slow growth of the market in the pandemic situation.

Global Neuromodulation Market: Segmentation

The global neuromodulation market is divided into technology, application, and region. Based on the technology, the global neuromodulation market is bifurcated into external neuromodulation (non-invasive) and internal neuromodulation. The application segment is classified into Parkinson's disease, pain management, dystonia, depression, epilepsy, tremor, and other applications.

Global Neuromodulation Market: Regional Analysis

North America is estimated to hold the largest share in the global neuromodulation market during the forecast period. This is primarily due to the increase in the prevalence of neurological disorders, growing geriatric population demanding non-invasive treatment for pain management, and increase in the adoption of neuromodulation therapies owing to its wide applications. In addition to this, presence of major players in the US is equally contributing to the growth of the market in North America. Europe is estimated to grow at a healthy rate. This is attributed to the increase in investment for the development of neuromodulation therapies. Asia Pacific is expected to grow rapidly and register the fastest growth during the forecast period. An increase in research and rise in neurological disorders are the factors that are fueling the growth of the market in this region.

Global Neuromodulation Market: Competitive Players

The global neuromodulation market is highly competitive. Key players are majorly focusing on partnerships, agreements, and product launches to strengthen their presence in the global market. Synapse Biomedical, Inc., LivaNova, Abbott, Boston Scientific Corporation, Medtronic, BioControl Medical, Neuronetics, NeuroPace, NeuroSigma, and Nevro Corporation are some of the major players that are operating in the global market.

Global Neuromodulation Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content


Frequently Asked Questions

An increase in prevalence of neurological disorders, a wide range of neuromodulation applications, and growing awareness of neurodegenerative disorders are some of the crucial factors that are fostering the growth of the global market. Furthermore, innovations in the devices and treatment may offer several opportunities for the growth of the global neuromodulation market over the forecast period.   

Synapse Biomedical, Inc., LivaNova, Abbott, Boston Scientific Corporation, Medtronic, BioControl Medical, Neuronetics, NeuroPace, NeuroSigma, and Nevro Corporation are some of the major players that are operating in the global market.

North America is estimated to hold the largest share in the global neuromodulation market during the forecast period. This is primarily due to the increase in the prevalence of neurological disorders, growing geriatric population demanding non-invasive treatment for pain management, and increase in the adoption of neuromodulation therapies owing to its wide applications. In addition to this, presence of major players in the US is equally contributing to the growth of the market in North America.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social